Multiple generations of University of Chicago Hematology/Oncology fellows at the Binaytara Foundation
University of Chicago Hematology/Oncology shared a post by Nitin Jain on X:
”We love seeing multiple generations of University of Chicago Hematology/Oncology fellows at meetings like this one!”
Quoting Nitin Jain’s post:
”With University of Chicago UChicago Leukemia Program team at the Binaytara Foundation meeting in Nashville!”
Dr. Nitin Jain is a Professor of Medicine at The University of Texas MD Anderson Cancer Center, Houston, USA. He leads the CAR T program for the Leukemia Department, MDACC, and received the Leukemia and Lymphoma Society (LLS) Scholar in Clinical Research and Translational Research Program awards in 2022. Specializing in acute and chronic leukemias, notably CLL and ALL, his research focuses on new drug development, reflected in his leadership of multiple investigator-initiated clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023